Cargando…
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer
SIMPLE SUMMARY: Patients diagnosed with endometrial cancer (EC), the most common gynaecological malignancy in women worldwide, cope with a disease associated with poor prognosis and limited treatment options after first-line therapy when it reaches an advanced or metastatic stage. Lately, small-mole...
Autores principales: | Megino-Luque, Cristina, Moiola, Cristian Pablo, Molins-Escuder, Clara, López-Gil, Carlos, Gil-Moreno, Antonio, Matias-Guiu, Xavier, Colas, Eva, Eritja, Núria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598629/ https://www.ncbi.nlm.nih.gov/pubmed/32987790 http://dx.doi.org/10.3390/cancers12102751 |
Ejemplares similares
-
Patient-Derived Xenograft Models for Endometrial Cancer Research
por: Moiola, Cristian P., et al.
Publicado: (2018) -
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer
por: Gatius, Sònia, et al.
Publicado: (2022) -
Síndrome de muerte súbita infantil (SMIS) /
por: Aguilera Polito, Elena
Publicado: (1988) -
Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis
por: Altadill, Tatiana, et al.
Publicado: (2017) -
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
por: Jové, Mariona, et al.
Publicado: (2016)